1 / 24

AMEBIASIS

AMEBIASIS. Emetine group : e.g. Emetine, dehydroemetine and its resinate. II. Quinoline derivatives: Halogenated hyroxyquinolines: Diiodohydroxyquinoline, iodochloroquine 4 – aminoquinolines: Chloroquine. III. Imidazole derivatives : Metronidazole, tinidazole, secnidazole, ornidazole

brier
Download Presentation

AMEBIASIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. AMEBIASIS

  2. Emetine group : e.g. Emetine, dehydroemetine and its resinate. • II. Quinoline derivatives: • Halogenated hyroxyquinolines: Diiodohydroxyquinoline, iodochloroquine • 4 – aminoquinolines: Chloroquine. • III. Imidazole derivatives: Metronidazole, tinidazole, secnidazole, ornidazole • IV. Antibiotics: Tetracyclines, paromomycin. • V. Miscellaneous: Diloxanide furoate and kurchi.

  3. Metronidazole: Reductive activation by intracellular transport proteins Reduced by the pyruvate:ferredoxin oxidoreductase system in the mitochondria of obligate anaerobes, which alters its chemical structure. Reduced intermediate particle interacts with intracellular targets — Cytotoxic intermediate particles interact with host cell DNA, resulting in DNA strand breakage and fatal destabilization of the DNA helix

  4. Metronidazole • Mechanism of action: • Enters bacteria via cell diffusion • Activated via single reduction step by bacteria forms radicals  reacts with nucleic acid  cell death • Spectrum of activity: • Anaerobic bacteria • Microaerophilic bacteria • Protozoa • Resistance: • Rare • Mechanism: decreased activation (↓ red ox reaction) of drug

  5. Indications: Anaerobe infections C. difficile H. pylori Bacterial vaginosis Trichomonas vaginitis Amebiasis Giardiasis Drug interactions: Ethanol Antacids CyA/tacrolimus Lithium Phenytoin Rifampin Warfarin Metronidazole

  6. Metronidazole: • Uses: • T vaginalis 2g single dose, 0.7% gel, 500mg – 1g • suppository • 2) Amoebiasis • 3) Giandaisies • 4) Anerobic infections – Bactericides, clostridium, • fusobacterium, peptococcus, peptosirgstococcus, • Eubacterium, H. pyloris. • 5) Polymicrobial infections.

  7. 6) Prophylaxis of postop mixed bacterial infection 7) Bacterial vaginosis 8) Pseudomembranous colitis 9) Crohns disease with perianal fistulas

  8. Distribution into tissue Therapeutic levels: PMNs Unobstructed biliary tract Pancreas CSF Empyema fluid Peritoneal fluid Hepatic abscess Pelvic tissues Vaginal/seminal fluid Adverse Effects: GI: N, V, epigastric distress Metallic taste Darkening of urine Peripheral neuropathy Pancreatitis Hepatitis Fever Reversible neutropenia Metronidazole

  9. IODOQUINOL EMETINE & DEHYDROEMETINE PAROMOMYCIN SULFATE DILOXANIDE FUROATE

  10. Asymptomatic Intestinal Infection Diloxanide 500 mg tid x 10d or- Iodoquinol 650 mg tid x 21d or- Paromomyin 10 mg/kg tid x 7d

  11. Mild to Moderate Intestinal Infection Metronidazole 750mg tid x 10d or- Tinidazole 2g od x 3d Plus- Luminal agent

  12. Mild to Moderate Intestinal Infection Alternative: Luminal agent Plus either- Tetracycline 250mg tid x 10d or- Erythromycin 500 mg qid x 10d

  13. Severe Intestinal Infection Metronidazole 750mg tid (500mg IV every 6 h) or Tinidazole plus Luminal agent Alternative: Luminal agent plus either Tetracycline or Dehydroemetine 1mg /kg SC/IM x 3-5d

  14. Hepatic / Extra intestinal Same as above Alternative: Dehydroemetine 1mg /kg S.C/IM x 3-5d Followed by (liver abscess only) Chloroquine 500mg bd x 2d, then 500mg od x21d Plus Luminal agent

  15. PENTAMIDINE: Pnenmocytosis sleeping sickness leishmaniasis Parenteral omebahized powder,

  16. LEISHMANIASIS:- 1) Liposonal anyrhotencin 2) Pentroalent antimonish. Sodium stibozhconate meglumine antimonite 3) Miltefosine 4) Pent amidine isethionate 5) paromorycin

  17. CUTANEOUS: 1) Pentacalant antimoniab 2) As above 3)Antifungals, allopunol

  18. TOPICAL: 1) Iutratesional antimony 2) Paromomycin oint 3) Cryotherapy 4) local heat 5) surgical removal

  19. SODIUM STIBOGLUCONATE:- IV / IM. Iutial t1/ 2 – 2 h Terminal t1/ 2 – 24 h 20 mg / kg 1d x 20 d

  20. ADR: G.I headache, arthralgia, rash - IM – Stenile abscers - ECG - Hemolytic anemia - LFT, renal effects,

  21. NITAZOXANIDE: General. Lanbia C. Parvum E. histohytica A. Iumbricoides Several tapumorns Increase Tizoxamide

  22. MILTEFOSINE:- - 2.5mg / kg / d x 28 d - Single dose amp B + 7 – 14 d miltepoine - G. I. - Decrease LFT - Not in Pregnancy - Resistance is a problem. Combination

  23. PAROMOMYCIN:- 11mg / kg x 21 d IM - ADR as with AGI

More Related